BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 171 filers reported holding BRIDGEBIO PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2,002 | +7.9% | 79 | +31.7% | 0.00% | – |
Q1 2024 | $1,856 | -23.4% | 60 | 0.0% | 0.00% | – |
Q4 2023 | $2,423 | +135.5% | 60 | +53.8% | 0.00% | – |
Q3 2023 | $1,029 | +66.0% | 39 | +8.3% | 0.00% | – |
Q2 2023 | $620 | +33.3% | 36 | +28.6% | 0.00% | – |
Q1 2023 | $465 | +165.7% | 28 | +21.7% | 0.00% | – |
Q4 2022 | $175 | – | 23 | -23.3% | 0.00% | – |
Q3 2022 | $0 | – | 30 | +114.3% | 0.00% | – |
Q2 2022 | $0 | – | 14 | -6.7% | 0.00% | – |
Q1 2022 | $0 | – | 15 | -40.0% | 0.00% | – |
Q4 2021 | $0 | – | 25 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 6,068,125 | $60,317,000 | 40.05% |
Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $308,746,000 | 6.20% |
M28 Capital Management LP | 513,300 | $5,102,000 | 5.33% |
GREAT POINT PARTNERS LLC | 1,050,000 | $10,437,000 | 2.51% |
Octagon Capital Advisors LP | 933,743 | $9,281,000 | 1.60% |
HHLR ADVISORS, LTD. | 5,362,014 | $53,298,000 | 1.40% |
VIKING GLOBAL INVESTORS LP | 26,620,991 | $264,613,000 | 1.22% |
Cormorant Asset Management, LP | 1,469,179 | $14,604,000 | 1.02% |
Fernwood Investment Management, LLC | 204,550 | $2,033,000 | 0.86% |
TANG CAPITAL MANAGEMENT LLC | 585,424 | $5,819,000 | 0.71% |